iStent reduced IOP and medications through 5 years

A cohort of patients with open-angle glaucoma or ocular hypertension implanted with an iStent after cataract surgery experienced reduced, safe and durable IOP and reduced medications through 5 years after the procedure, according to a study.
“Implantation of a single iStent during small-incision cataract surgery treating elevated IOP by ocular hypertension or POAG is a sustained, safe and effective surgical glaucoma treatment through 5 years postoperative. The majority of our patients love this very special ‘dropless’ comfort knowing that their IOP is controlled by the iStent

Full Story →